View in EDS HTML Full Text PDF Full Text

JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.

Saved in:
Bibliographic Details
Title: JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.
Authors: Wu Q; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States., Mills EA; Alzheimer's Drug Discovery Foundation, New York, NY, United States., Wang Q; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States., Mao G; School of Public Health, University of Michigan, Ann Arbor, MI, United States., Mao-Draayer Y; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, Multiple Sclerosis Center of Excellence, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Source: Frontiers in neurology [Front Neurol] 2025 Aug 04; Vol. 16, pp. 1584083. Date of Electronic Publication: 2025 Aug 04 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40832152
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Mills+EA%22">Mills EA</searchLink>; Alzheimer's Drug Discovery Foundation, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Mao+G%22">Mao G</searchLink>; School of Public Health, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Mao-Draayer+Y%22">Mao-Draayer Y</searchLink>; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, Multiple Sclerosis Center of Excellence, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101546899%22">Frontiers in neurology</searchLink> [Front Neurol] 2025 Aug 04; Vol. 16, pp. 1584083. <i>Date of Electronic Publication: </i>2025 Aug 04 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101546899 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2295 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642295%22">16642295 </searchLink><i>NLM ISO Abbreviation: </i>Front Neurol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40832152
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fneur.2025.1584083
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1584083
    Titles:
      – TitleFull: JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu Q
      – PersonEntity:
          Name:
            NameFull: Mills EA
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Mao G
      – PersonEntity:
          Name:
            NameFull: Mao-Draayer Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 08
              Text: 2025 Aug 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1664-2295
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in neurology
              Type: main
ResultId 1